PROPEQUITY.NS,0P0001OP2B,104400

PROPEQUITY · General/Diversified · NSE

₹293

Current Market Price

Near Fair Value

Fair Value (DCF)

₹252

Margin of Safety

-14.0%

Updated 6h ago

DCF Sensitivity →

YieldIQ Score

62/100

Piotroski F-Score

5/9

Economic Moat

Wide

Confidence

69%

ROE

Debt/Equity

0.00

WACC

11.1%

Market Cap

₹307 Cr

Quality & Valuation

Neutral model outputs — no recommendations.

ROCE

Return on capital employed

EV / EBITDA

Enterprise multiple

Debt / EBITDA

Leverage vs earnings

Interest Coverage

EBIT covers interest

Current Ratio

Short-term liquidity

Asset Turnover

0.43×

Revenue per ₹ of assets

Revenue CAGR (3Y)

23.8%

3-year revenue growth

Revenue CAGR (5Y)

5-year revenue growth

DCF Scenario Analysis

vs CMP ₹292.95

Bear case

₹161.77

MoS -81.1%

Base case

₹251.94

MoS -16.3%

Bull case

₹260.58

MoS -12.4%

Ratio Trends

Historical ratio trends for PROPEQUITY are being prepared. Once ready, this section will show multi-year trajectories of ROE, ROCE, margins, leverage, and valuation multiples.

Historical Financials

Historical financials for PROPEQUITY are being prepared. Check back shortly for a 5-year view of revenue, earnings, cash flow, and balance-sheet trends.

Peer Comparison

Peers not yet ranked for PROPEQUITY. Comparable companies and side-by-side valuation will appear here once the peer set is established.

Dividend History

No dividend events recorded for PROPEQUITY in the last 10 years.

AI Analysis Summary

Model-generated description of metrics. Not investment advice. PROPEQUITY.NS,0P0001OP2B,104400 (PROPEQUITY.NS) trades at 292.95 vs a model fair value of 251.94, a gap of -14.0%. Piotroski F-score: 5/9...

Read full AI analysis →

Run Full Interactive Analysis

Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.

Analyse PROPEQUITYNow →

Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.